Category
Primary
infectious-diseases · embed-ft 0.36
Tree path
Medical Health › Diseases and Conditions › Infectious Diseases
Group (tier-1)
Tech stack
CDN
AI readiness
Compliance (GEO / GDPR)
TLD
Overview
Title
ABRYSVO® (Respiratory Syncytial Virus Vaccine) by Pfizer | Risk Info
Description
ABRYSVO is an RSV vaccine for adults 75+ & 50-74 with certain conditions & eligible women 32-36 weeks pregnant to help protect their baby from respiratory disease caused by RSV.
Final URL
Language
en (html)
Scanned at
2026-06-16 16:27:16